Vaping, smoking and risk of early onset lung cancer
Abstract
Lung cancer is the leading cause of cancer mortality worldwide, including young adults. While it is well known that cigarette smoking is the dominant risk factor for lung cancer, the inhalation of heated aerosolized vaping oil has now replaced cigarette smoking as the major source of nicotine among young people. We, therefore, studied the potential role of both vaping and cigarette smoking in the development of early onset lung cancer. Using a case-control study design, we compared the smoking and vaping habits of 256 young adults (< 50 years of age) diagnosed with pathologically confirmed lung cancer to that of 2,921 control subjects without cancer that were group matched by age (within 5 years), sex, race and location to the cases. The odds ratio for those who both vaped and smoked (OR = 13.8, 95% CI: 7.7-24,9) was 2.8 times higher than for smoking alone (OR = 5.0, 95% CI: 3.7-6.9). Pulmonary adenocarcinomas accounted for 72% of the early onset lung tumors among the cases, and risk estimates for this specific cell type were 3.7 times higher for those who smoked and vaped (OR = 14.8, 95% CI = 8.0-27.4) compared to those who only smoked (OR = 4.0, 95% CI = 2.9-5.6). Our findings suggest that compared to smoking alone, vaping and smoking together accelerate lung cancer risk among young people, particularly in the development of pulmonary adenocarcinoma.
How strong is the evidence?
Evidence Hub reads this as a case-control, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 2,921 participants or records.
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.